Clinical Trials Directory

Trials / Unknown

UnknownNCT05394727

Application of Needle-free Injection of Insulin in Patients With Gestational Diabetes Mellitus

Application of Needle-free Injection of Insulin in Pregnant Women With Gestational Diabetes Mellitus

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Nanfang Hospital, Southern Medical University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is about the application of needle-free injection device in GDM patients in order to observe the variation of blood glucose and patients' experience compared to the traditional insulin pen injection. To provide evidence for the application of needle-free syringe injection in GDM patients.

Detailed description

This study is a prospective, randomized, unblinded,crossover and controlled clinical trail. The first patient was enrolled on November 1, 2019. The follow-up visit of all enrolled patients in our center will be finished on June 30, 2021. There are two arms in our study : Test Group(IG,n=20) and Control Group(CG,n=20), 40 patients totally. Test group: "Needle-free injection device, Then traditional insulin pen" Patients first received needle-free syringe for insulin injection 3\~4 times per day for 2 weeks. After the period of 2 weeks, they then received conventional insulin pen for insulin injection 3\~4 times per day for 2 weeks. Control group: "Traditional insulin pen , Then Needle-free injection device" Patients first received conventional insulin pen for insulin injection 3\~4 times per day for 2 weeks. After the period of 2 weeks, they then received needle-free syringe for insulin injection 3\~4 times per day for 2 weeks.

Conditions

Interventions

TypeNameDescription
DEVICENeedle-free injection device, Then traditional insulin penPatients first received needle-free syringe for insulin injection 3\~4 times per day for 2 weeks. After the period of 2 weeks, they then received conventional insulin pen for insulin injection 3\~4 times per day for 2 weeks.
DEVICETraditional insulin pen , Then Needle-free injection devicePatients first received conventional insulin pen for insulin injection 3\~4 times per day for 2 weeks. After the period of 2 weeks, they then received needle-free syringe for insulin injection 3\~4 times per day for 2 weeks.

Timeline

Start date
2021-04-01
Primary completion
2023-06-30
Completion
2023-06-30
First posted
2022-05-27
Last updated
2023-03-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05394727. Inclusion in this directory is not an endorsement.